Abstract:BACKGROUND:Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors. Despite the advances in therapy over the years, its mortality remains high. The aim of this study was to evaluate the expression of small ubiquitin-like modifier (SUMO) proteases 1 (SENP1) in NSCLC tissues and its role in the regulation of vascular endothelial growth factor (VEGF) expression. We also investigated the association between the expression level of SENP1 and the clinicopathological features and survival of the patients.METHODS:A SENP1 small interfering RNA (siRNA) was constructed and transfected into the NSCLC cells. VEGF gene expression was analyzed by real-time polymerase chain reaction (RT-PCR). Immunohistochemistry staining was used to assess the expression of SENP1 in 100 NSCLC patients and its association with the clinicopathological features and survival was analyzed.RESULTS:VEGF expression was significantly higher in NSCLC tissues than in normal lung tissues. Inhibition of SENP1 by siRNA was associated with decreased VEGF expression. SENP1 was over-expressed in 55 of the 100 NSCLC samples (55%) and was associated with a moderate and low histological tumor grade (3.6%, 38.2%, and 58.2% in high, moderate and low differentiated tumors, respectively, P = 0.046), higher T stage (10.9% in T1, and 89.1% in T2 and T3 tumor samples, P < 0.001) and TNM stage (10.9% in stage I, and 89.1% in stages II and III tumor samples, P < 0.001). The rate of lymph node metastasis was significantly higher in the SENP1 over-expression group (76.4%) than that in the SENP1 low expression group (33.3%, P < 0.001). Sixty three patients received postoperative chemotherapy, including 34 with SENP1 over-expression and 29 with SENP1 low expression. Among the 34 patients with SENP1 over-expression, 22 (64.7%) patients developed recurrence or metastasis, significantly higher than those in the low expression group 27.6% (8/29) (P = 0.005). Multivariate Cox regression analysis showed that lymph node metastasis (P = 0.015), TNM stage (P = 0.001), and SENP1 expression level (P = 0.002) were independent prognostic factors for the survival of NSCLC patients.CONCLUSIONS:SENP1 may be a promising predictor of survival, a predictive factor of chemo-sensitivity for NSCLC patients, and potentially a desirable drug target for lung carcinoma target therapy.

Overexpression of Small Ubiquitin-Like Modifier Protein-Specific Protease 5 in Oral Squamous Cell Carcinoma and Its Association with Differentiation

Overexpression of SENP5 in Oral Squamous Cell Carcinoma and Its Association with Differentiation.

Overexpression of SENP3 in Oral Squamous Cell Carcinoma and Its Association with Differentiation

Sentrin/small ubiquitin-like modifier-specific protease 5 protects oral cancer cells from oxidative stress-induced apoptosis.

Expression and Prognosis Analysis of SUMOylation Regulators in Oral Squamous Cell Carcinoma Based on High-Throughput Sequencing

Overexpression of SENP5 in tongue squamous cell carcinoma and the association with differentiation

Expression and Clinical Significance of Small Ubiquitin-Like Modifier-1 and P53 Protein in Uterine Leiomyosarcoma

Small Ubiquitin-Like Modifier Protein-Specific Protease 1 and Prostate Cancer

Role of Desumoylation in the Development of Prostate Cancer

[Sumo-Specific Protease 1 and Cancer].

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma

Sumo-1 Expression Modulates Non-Small Cell Lung Cancer Progression

Over-expression of Small Ubiquitin-Like Modifier Proteases 1 Predicts Chemo-Sensitivity and Poor Survival in Non-Small Cell Lung Cancer.

Over-expression of Small Ubiquitin-Related Modifier-1 and Sumoylated P53 in Colon Cancer.

Small Ubiquitin-Like Modifier and Cancer

Post-Translational Modification of SUMOylation and Cancer: A Brief Review

Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer

Upregulation of SENP3/SMT3IP1 Promotes Epithelial Ovarian Cancer Progression and Forecasts Poor Prognosis

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

Important Role of SUMOylation of Spliceosome Factors in Prostate Cancer Cells.

Dissecting Multiple Roles of SUMOylation in Prostate Cancer.